Utilizing Quantitative Proteomics to Identify Species-Specific Protein Therapeutic Targets for the Treatment of Leishmaniasis.

Krobthong, Sucheewin; Yingchutrakul, Yodying; Samutrtai, Pawitrabhorn; Hitakarun, Atitaya; Siripattanapipong, Suradej; Leelayoova, Saovanee; Mungthin, Mathirut; Choowongkomon, Kiattawee

Krobthong, Sucheewin; Yingchutrakul, Yodying; Samutrtai, Pawitrabhorn; Hitakarun, Atitaya; Siripattanapipong, Suradej; Leelayoova, Saovanee; Mungthin, Mathirut; Choowongkomon, Kiattawee.

Afiliação

Krobthong S; Genetic Engineering and Bioinformatics Program, Kasetsart University, Bangkok 10900, Thailand.
Yingchutrakul Y; Center for Neuroscience, Faculty of Science, Mahidol University, Bangkok 10400, Thailand.
Samutrtai P; Center for Neuroscience, Faculty of Science, Mahidol University, Bangkok 10400, Thailand.
Hitakarun A; National Omics Center, NSTDA, Pathum Thani 12120, Thailand.
Siripattanapipong S; Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand.
Leelayoova S; Suphanburi Campus Establishment Project, Kasetsart University, Suphan Buri 72150, Thailand.
Mungthin M; Department of Microbiology, Faculty of Science, Mahidol University, Bangkok 10400, Thailand.
Choowongkomon K; Department of Parasitology, Phramongkutklao College of Medicine, Bangkok 10400, Thailand.

ACS Omega ; 7(15): 12580-12588, 2022 Apr 19.

Article em En | MEDLINE | ID: mdl-35474788

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: ACS Omega Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Tailândia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google